A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against treatment-resistant depression, giving biotechs hope that this type of drug will become a viable option for healthcare systems to use for mental health conditions.
一種需要更短臨床監督期的致幻劑鼻噴霧劑已顯示出對抗難治性抑郁癥的潛力，這讓生物技術公司看到了希望，即此類藥物有望成為醫療系統用于治療精神疾病的可行選擇。
您已閱讀8%（348字），剩余92%（4222字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。